Nuheara Limited

Nuheara Limited

NUHRF
Nuheara LimitedUS flagOther OTC
0.00
USD
- -
- -
54,109.00Market Cap
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
Revenue per Share
- -
- -
- -
- -
- -
- -
0.08
0.1
0.05
0.03
0.14
0.04
- -
Basic EPS, GAAP
-0.69
-0.68
-0.38
-0.3
-0.17
-0.44
-0.15
-0.18
-0.22
-0.23
-0.09
-0.15
- -
Free Cash Flow per Basic Share
-0.63
-0.5
-0.41
-0.27
-0.11
-0.09
-0.24
-0.1
-0.08
-0.07
-0.05
-0.05
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.44
-0.05
0.16
-0.07
0.02
0.1
0.19
0.35
0.2
0.11
0.15
-0.01
- -
Tangible Book Value per Share
0.45
0.1
0.23
0.01
0.03
0.13
0.14
0.26
0.12
0.03
0.1
-0.03
- -
Basic Weighted Avg Shares
2
2
3
4
4
15
31
41
46
51
78
93
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
2
4
2
2
11
4
2
Operating Margin (%)
- -
- -
- -
- -
- -
- -
-244.14
-272.45
-703.55
-1,073.35
-117.55
-534.29
-857.08
Depreciation Expense
- -
- -
- -
- -
- -
- -
1
2
3
4
4
4
4
Net Income, GAAP
-1
-2
-1
-1
-1
-7
-5
-7
-10
-12
-7
-14
-13
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
-196.23
-187.16
-451.94
-672.06
-67.04
-370.84
-653.33
Working Capital
1
- -
1
- -
- -
2
3
10
5
3
7
1
5
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
- -
2
2
Total Equity
1
- -
1
- -
- -
2
7
15
11
6
13
3
5
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-105.15
- -
- -
- -
- -
-828.51
-131.58
-74.5
-85.85
-157.64
-81.94
- -
- -

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
185.71%
4.44%
64.64%
Free Cash Flow
47.01%
-5.16%
-36.6%
Net Income, GAAP
88.58%
20.1%
-11.98%
Sales/Revenue/Turnover
- -
67.57%
-50.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
11
2022
- -
- -
- -
- -
4
2023
- -
- -
- -
- -
2

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
-0.09
2022
- -
- -
- -
- -
-0.15
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Justin Paul Miller
Full Time Employees
39
Sector
Technology
Industry
Consumer Electronics
Address
190 Aberdeen Street Perth WA Australia 6003
IPO Date
May 11, 2016
Business
Nuheara Limited (ASX:NUH; OTC:NUHRF), an Australia-based medical device company founded in 2007 and headquartered at 190 Aberdeen Street, Northbridge, Western Australia, develops and commercializes multi-functional smart hearing technology and products as regulated medical devices; core offerings include IQbuds2 MAX hearing buds featuring Ear ID personalization, hybrid active noise cancellation, Speech in Noise Control, directional Focus, World Blend and high-fidelity audio streaming; IQstream TV, a low-latency smart TV box for personalized stereo TV sound delivery to IQbuds; Bluetooth Transmitter for connecting IQbuds to non-Bluetooth devices such as in-flight entertainment or stereos; and accessory replacement parts including charging cases and soundport meshes. The company targets consumers with mild-to-moderate hearing loss through direct-to-consumer sales, consumer electronics retailers, professional hearing clinics, pharmacies and specialty outlets worldwide, with subsidiaries spanning the US, UK, Canada, Netherlands and Australia including Nuheara Inc and Nuheara IP Pty Ltd. Nuheara operates in the underserved self-fitting hearing aid segment, leveraging proprietary intelligent audio processing for augmented hearing and cable-free connectivity to personal devices. Recent developments encompass US FDA clearance for its self-fitting HP Hearing PRO air-conduction hearing aid launched in early 2023 and distributed via partnerships with retailers including Walmart, Target.com, CVS Health, InnerScope Hearing Technologies and Fuel Medical; a strategic worldwide trademark license agreement with HP Inc in April 2022; a July 2022 partnership with Realtek Semiconductor Corporation followed by AU$2.5 million follow-on funding in September 2022 to co-develop OEM chipsets and penetrate hearing solution markets; multiple capital raisings totaling over AU$10 million in 2022-2023 including AU$4.4 million in June 2023 and a retail entitlement offer in October 2023 to accelerate US commercialization and production scaling; board appointments such as Leroy Liu in March 2023 and executive team restructuring in 2024; showcase of next-generation products at CES 2024; and a strategic review announced May 2024 alongside variation of managing director employment terms.